跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INOSERT 100 TABLET 100MG - HSA Drug Approval Details
Approvals
/
HSA
/
INOSERT 100 TABLET 100MG
Approved
THERAPEUTIC
INOSERT 100 TABLET 100MG
IPCA LABORATORIES LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
May 26, 2015
Approval ID
e9a76d5b6289b63c
Company
IPCA LABORATORIES LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
e9a76d5b6289b63c
Drug Name
INOSERT 100 TABLET 100MG
Product Name
INOSERT 100 TABLET 100MG
Approval Number
SIN14789P
Approval Date
2015-05-26
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N06AB06
Atc Item Name
sertraline
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Sertraline Hydrochloride 111.90 mg eqv. to Sertraline
100mg
SERTRALINE HYDROCHLORIDE 111.9 MG EQV. TO SERTRALINE
100 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 26, 2015
Approval ID
e9a76d5b6289b63c
Type
Therapeutic
Back to HSA Approvals